Find trials
Search tips

Patient Self-collection Device for EDTA Whole-blood Assessment of Tacrolimus Therapeutic Dosage Monitoring

Overview

About this study

The objectives of this study are to compare the measured tacrolimus concentrations in patient self-collected capillary EDTA whole-blood compared to venipuncture obtained EDTA whole-blood, to establish the rate of quantity not sufficient (QNS), clotting, or other pre-enalytical fails using patient self-collected capillary EDTA whole-blood, and to gauge the patient perspective on self-collection versus venipunture for comfort and convenience.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults (≥ 18 years).
  • Having a clinically ordered TAKRO venipuncture (VP) scheduled at Charlton Lab Services (CLS).

Exclusion Criteria:

 

  • Age < 18 years.
  • Unable to provide informed consent for research participation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/3/23. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jeffrey Meeusen, Ph.D.

Open for enrollment

Contact information:

Jeffrey Meeusen Ph.D.

(507) 284-9939

Meeusen.Jeffrey@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20563914

Mayo Clinic Footer